Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fay

Showing results (291-300 of 395) with videos related to

Pageof 40
Sort By:
The Journal of Allergy and Clinical Immunology|July 14, 2007
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entitiesIrina Maric, Jamie Robyn, Dean D Metcalfe, et al.
Plos Neglected Tropical Diseases|May 17, 2011
Seasonality and prevalence of Leishmania major infection in Phlebotomus duboscqi Neveu-Lemaire from two neighboring villages in central MaliJennifer M Anderson, Sibiry Samake, Giovanna Jaramillo-Gutierrez, et al.
The Journal of Infectious Diseases|November 6, 2012
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stagesCharlotte V Hobbs, Tatiana Voza, Patricia De La Vega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trialToni K Choueiri, David J Figueroa, André P Fay, et al.
Scientific Reports|July 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinationsYvonne Azasi, Shannon K Gallagher, Ababacar Diouf, et al.
Plos One|October 12, 2012
Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malariaRuth D Ellis, Yimin Wu, Laura B Martin, et al.
The Journal of Experimental Medicine|September 9, 2005
MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cellsSergey Filippov, Gerald C Koenig, Tae-Hwa Chun, et al.
The Lancet. Microbe|February 22, 2021
Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics studyOm Prakash Singh, Puja Tiwary, Anurag Kumar Kushwaha, et al.
Vaccine|September 4, 2025
Adopting the estimand framework in prophylactic vaccine trialsFrancois Beckers, Naveen Karkada, Ye Yang, et al.
Trials|January 26, 2024
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trialNginache Nampota-Nkomba, Osward M Nyirenda, Jane Mallewa, et al.
Pageof 40

Showing results (291-300 of 395) with videos related to

Sort By:
Pageof 40
The Journal of Allergy and Clinical Immunology|July 14, 2007
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entitiesIrina Maric, Jamie Robyn, Dean D Metcalfe, et al.
Plos Neglected Tropical Diseases|May 17, 2011
Seasonality and prevalence of Leishmania major infection in Phlebotomus duboscqi Neveu-Lemaire from two neighboring villages in central MaliJennifer M Anderson, Sibiry Samake, Giovanna Jaramillo-Gutierrez, et al.
The Journal of Infectious Diseases|November 6, 2012
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stagesCharlotte V Hobbs, Tatiana Voza, Patricia De La Vega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trialToni K Choueiri, David J Figueroa, André P Fay, et al.
Scientific Reports|July 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinationsYvonne Azasi, Shannon K Gallagher, Ababacar Diouf, et al.
Plos One|October 12, 2012
Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malariaRuth D Ellis, Yimin Wu, Laura B Martin, et al.
The Journal of Experimental Medicine|September 9, 2005
MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cellsSergey Filippov, Gerald C Koenig, Tae-Hwa Chun, et al.
The Lancet. Microbe|February 22, 2021
Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics studyOm Prakash Singh, Puja Tiwary, Anurag Kumar Kushwaha, et al.
Vaccine|September 4, 2025
Adopting the estimand framework in prophylactic vaccine trialsFrancois Beckers, Naveen Karkada, Ye Yang, et al.
Trials|January 26, 2024
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trialNginache Nampota-Nkomba, Osward M Nyirenda, Jane Mallewa, et al.
Pageof 40